查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2001110

瞳孔計市場：按類型、技術、銷售管道、應用和最終用戶分類－2026-2032年全球市場預測

Pupillometer Market by Type, Technology, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，瞳孔計市值將達到 5.5939 億美元，到 2026 年將成長至 6.214 億美元，到 2032 年將達到 10.9761 億美元，年複合成長率為 10.10%。

主要市場統計數據
基準年 2025 5.5939億美元
預計年份：2026年 6.214億美元
預測年份 2032 1,097,610,000 美元
複合年成長率 (%) 10.10%

本文簡要概述了瞳孔擴張在臨床環境和研究中不斷演變的作用，重點關注其診斷價值、便攜性和新興的整合趨勢。

瞳孔測量已從一種小眾的診斷輔助手段發展成為臨床實踐、調查和篩檢流程整體廣泛認可的工具。感測器設計、影像處理演算法和符合外形規格的進步，拓展了臨床醫生採集瞳孔資料的場所和方法，使得床邊快速評估和門診環境下更一致的資料收整合為可能。隨著人們對神經系統和眼科疾病預後的關注度不斷提高，瞳孔測量解決方案的價值日益凸顯，不僅在於其即時的診斷效用，還在於其能夠融入長期照護路徑和多模態診斷體系。

技術創新、人工智慧和即時護理連接如何改變設備設計、臨床工作流程和瞳孔測量的未來。

瞳孔測量技術領域正經歷著一場根本性的變革，這主要得益於光學、嵌入式處理和軟體智慧領域的創新。緊湊型感測器陣列和改進的低光成像技術正在縮小解析度和便攜性之間的差距，使手持設備能夠達到以往只有固定設備才能獲得的數據品質。同時，電腦視覺和機器學習技術也開始著手解決噪音、運動偽影和檢查者間差異等問題，產生更可靠、更可重複的測量結果，供醫療專業人員在臨床環境中使用。

評估 2025 年美國關稅調整對醫療設備製造、零件採購和商業化策略的供應鏈和成本的累積影響。

2025年實施的關稅調整對醫療設備供應商的製造業經濟、籌資策略和供應鏈結構產生了多方面的影響。進口光學元件、半導體成像感測器和特殊玻璃的關稅提高，導致醫療設備製造商的投入成本上升，尤其是那些依賴全球採購網路的製造商。這些成本壓力促使製造商重新評估其採購地點，並加快討論部分國內生產、策略性庫存緩衝和多供應商認證等措施，以降低未來政策變化帶來的風險。

從策略性細分的觀點揭示了驅動決策和採用模式的產品、最終用戶、技術、應用和分銷動態。

透過對設備、最終用戶、技術、應用和通路進行清晰的分類，可以揭示產品普及和差異化發生的地點。按類型分類，設備可分為手持式和桌面式。手持式設備優先考慮便攜性、快速分診和低資本投入，而桌面式設備則強調高解析度成像和與其他診斷平台的整合。依最終使用者分類，診所、診斷中心、醫院和研究機構的採用模式各不相同，每個機構對處理能力、消毒和互通性都有其獨特的需求。

區域需求模式和關鍵區域的基礎設施因素會影響採購、臨床部署和區域商業化路徑。

地理環境以不同的方式影響臨床應用、報銷環境和供應鏈決策。在美洲，需求往往集中在住院和急診醫療應用領域，這得益於成熟的採購網路和對快速決策工具的重視。該地區的另一個特點是已做好在三級醫療機構試點部署創新設備的準備。在歐洲、中東和非洲（EMEA）地區，不同的法規結構和分散的醫療基礎設施造就了多元化的機遇，而本地臨床檢驗和與本地分銷商的合作往往是市場准入的關鍵因素。在亞太地區，門診服務的快速擴張和對診斷能力的投資，使得人們對擴充性擴展且經濟高效的瞳孔測量解決方案的需求日益成長，同時也推動了對本地製造的投資，從而縮短了前置作業時間並降低了關稅風險。

主要醫療設備製造商之間的競爭和企業策略，包括產品差異化、夥伴關係、製造地和服務模式。

製造商和服務供應商的競爭行為呈現出幾個通用的主題，共同塑造了競爭格局。首先，產品差異化越來越依賴軟體功能，而不僅僅是硬體規格，例如訊號處理、自動偽影去除和決策支援。投資於檢驗的分析功能和以用戶為中心的介面的公司正在贏得臨床機構的信任，並能夠證明其高價策略的合理性，從而支持持續的軟體維護和改進。其次，與醫療系統、學術機構和科技公司建立策略夥伴關係，正在加速臨床檢驗，並拓展設備的適用場景，從而促進關鍵意見領袖（KOL）的快速採納。

為行業領導者提供營運和策略建議，以增強韌性、加快部署速度並在瞳孔計解決方案中實現臨床可靠性。

產業領導者應優先考慮一系列協調一致的舉措，以整合產品開發、供應鏈策略和臨床證據的產生。首先，投資於模組化設計，以便在不影響監管合規性的前提下更換組件，從而降低關稅帶來的成本衝擊，並實現供應商的快速切換。其次，加快軟體檢驗工作，以證明其能夠在不同的患者群體和操作環境下實現不受人為因素影響的測量。這種方法能夠增強臨床信心，並支持更廣泛地整合到臨床診療路徑中。

本報告提供了一個穩健的研究框架，詳細說明了支撐所提出的發現和結論的資料來源、檢驗方法和分析方法。

本研究結合定性和定量方法，以確保獲得全面而深入的見解。研究人員對臨床醫生、採購負責人和設備工程師進行了訪談，以直接了解他們對臨床需求、營運限制和採購因素的看法。同時，研究人員也有系統地查閱了技術文獻、監管申報文件和設備規格，以整理技術架構、檢驗方法和性能基準。供應鏈分析和供應商訪談則提供了有關組件採購、前置作業時間和成本風險的詳細資訊。

在瞳孔測量領域，這為尋求優先考慮投資和營運應對措施的相關人員提供了一個簡潔的市場動態和技術趨勢的整合，以及相應的影響。

瞳孔測量技術正處於轉折點，技術成熟度、臨床應用需求和操作要求在此交匯融合，為改善診斷流程和研究應用創造了重要機會。感測器和分析技術的進步打破了便攜性和資料完整性之間的傳統權衡，使得各種外形規格能夠滿足特定的臨床和研究需求。雖然政策變革和關稅調整帶來了新的操作考量，但也促進了區域組裝、供應商多元化和設計模組化等戰略應對措施的實施，從而提升了設備的長期韌性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：瞳孔計市場：依類型分類

  • 手持式
  • 桌面型

第9章 瞳孔計市場：依技術分類

  • 紅外線的
    • 中紅外線
    • 近紅外線
  • 光學的
  • 映像基礎
    • 2D成像
    • 3D成像

第10章：瞳孔計市場：依通路分類

  • 離線
    • 直銷
    • 銷售代理
  • 線上

第11章 瞳孔計市場：依應用領域分類

  • 臨床診斷
    • 神經病學
    • 眼科
  • 篩檢

第12章：瞳孔計市場：依最終用戶分類

  • 診所
  • 診斷中心
  • 醫院
  • 研究機構

第13章 瞳孔計市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：瞳孔計市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：瞳孔計市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國瞳孔計市場

第17章 中國瞳孔計市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Adaptica Srl
  • AMETEK GmbH
  • Brightlamp, Inc.
  • Essilor Instruments USA, Inc.
  • Good-Lite Company
  • HAAG-STREIT AG
  • IDMED SAS
  • Keeler Ltd.
  • Konan Medical USA, Inc.
  • Luneau Technology Group SAS
  • MediWorks Co., Ltd.
  • NeurOptics, Inc.
  • NIDEK Co., Ltd.
  • OICO-Ophthalmic Instrument Company
  • Reichert Technologies, Inc.
  • Rodenstock GmbH
  • Visionix Ltd.
Product Code: MRR-F927BA462D63

The Pupillometer Market was valued at USD 559.39 million in 2025 and is projected to grow to USD 621.40 million in 2026, with a CAGR of 10.10%, reaching USD 1,097.61 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 559.39 million
Estimated Year [2026] USD 621.40 million
Forecast Year [2032] USD 1,097.61 million
CAGR (%) 10.10%

A concise orientation to pupillometry's evolving role across clinical practice and research, highlighting diagnostic value, portability, and emerging integration trends

Pupillometry has moved from a niche diagnostic adjunct to a recognized tool across clinical practice, research, and screening workflows. Advancements in sensor design, imaging algorithms, and ergonomic form factors have expanded where and how clinicians collect pupil metrics, enabling faster bedside assessments and more consistent data capture in outpatient environments. As attention to neurologic and ophthalmic outcomes grows, pupillometer solutions are increasingly evaluated not only for their immediate diagnostic utility but also for their ability to integrate into longitudinal care pathways and multi-modal diagnostic ecosystems.

Transitioning from proof-of-concept devices to widely adopted clinical instruments requires alignment across several domains: demonstrable reliability across diverse patient populations, streamlined clinical workflows that minimize training burden, and regulatory clarity that supports hospital procurement. Concurrently, research groups have driven methodological standardization, producing protocols that improve comparability across studies and support broader clinical acceptance. Taken together, these forces are elevating pupillometry from a specialist measurement technique to an operationally viable clinical instrument with applications that span acute triage, chronic disease monitoring, and basic neuroscience research.

How technological innovation, artificial intelligence, and point-of-care connectivity are reshaping device design, clinical workflows, and the future of pupil measurement

The landscape for pupillometer technologies is undergoing fundamental shifts driven by innovation in optics, embedded processing, and software intelligence. Compact sensor arrays and improvements in low-light imaging have reduced the trade-offs between resolution and portability, enabling handheld devices to deliver data quality that previously required stationary equipment. Simultaneously, computer vision and machine learning have begun to address noise, motion artifacts, and inter-operator variability, producing more robust, repeatable measures that clinicians can trust at the point of care.

Beyond core hardware changes, integration with electronic health records and telehealth platforms has altered expectations for data accessibility and longitudinal tracking. Clinicians now anticipate immediate availability of pupil metrics alongside other vital signs, with integrated decision-support that flags deviations from individualized baselines. Regulatory attention has also intensified, prompting manufacturers to design devices and validation studies that align with clinical trial evidence standards. As a result, commercialization strategies are shifting from single-product launches toward platform approaches that combine hardware, validated analytics, and services to support adoption and reimbursement discussions.

Assessing the cumulative supply chain and cost impacts of United States tariff adjustments in 2025 on device manufacturing, component sourcing, and commercialization strategies

Tariff adjustments implemented in 2025 have exerted a multi-dimensional influence on manufacturing economics, procurement strategies, and supply chain configuration for medical device suppliers. Increases in duties on imported optical components, semiconductor imaging sensors, and specialized glass translate into higher input costs for device producers, particularly those reliant on globalized sourcing networks. These cost pressures have encouraged manufacturers to re-evaluate sourcing footprints and to accelerate conversations about partial reshoring, strategic inventory buffering, and multi-supplier qualification to mitigate exposure to future policy volatility.

Procurement teams and distributors are responding by revising contractual terms, seeking longer lead-time commitments, and exploring localized assembly options that reduce tariff incidence. These adaptations can introduce short-term complexity and capital intensity as facilities and supplier relationships are restructured, but they also create an opportunity to shorten supply chains and increase visibility into component quality. For product roadmaps, the tariff environment has encouraged prioritization of designs that reduce dependence on tariff-sensitive inputs, enable component substitution, and leverage modular architectures that facilitate regionalized production. Collectively, these shifts change the calculus for pricing, margin management, and long-term manufacturing resilience, and they emphasize the need for scenario planning and active supplier relationship management.

Strategic segmentation perspectives that reveal product, end-user, technology, application, and distribution dynamics driving decision-making and adoption patterns

Clear segmentation of devices, end users, technologies, applications, and distribution pathways illuminates where adoption and differentiation will occur. Based on Type, devices cluster into handheld and tabletop designs; handheld units prioritize portability, rapid triage, and lower capital intensity, while tabletop configurations emphasize high-resolution imaging and integration with other diagnostic platforms. Based on End User, adoption patterns vary across clinics, diagnostic centers, hospitals, and research institutes, with each setting imposing distinct requirements for throughput, sterilization, and interoperability.

Based on Technology, solutions are organized across infrared, optical, and video-based approaches, where infrared techniques span mid infrared and near infrared subtypes, and video-based systems split into 2D imaging and 3D imaging modalities; each technological choice implicates trade-offs in sensitivity to ambient light, spatial resolution, and computational load. Based on Application, pupillometers support clinical diagnosis, research, and screening activities, where clinical diagnosis often concentrates on neurology and ophthalmology subdomains that demand regulatory-grade validation and reproducibility. Based on Distribution Channel, devices are supplied through offline and online mechanisms, with offline channels bifurcating into direct sales and distributors; the choice of channel influences training models, service contracts, and purchasing cycles.

When these segmentation dimensions are considered together, they reveal natural product-market fits and pain points. Handheld infrared devices distributed via direct sales to emergency clinics can excel in rapid triage use cases, whereas tabletop 3D imaging systems positioned through distributors to hospitals and research institutes will emphasize analytics fidelity and multi-modal integration. Understanding these alignments enables manufacturers and purchasers to prioritize clinical validation efforts, plan targeted commercial outreach, and design service models that reflect the operational constraints of each end-user cohort.

Regional demand patterns and infrastructure factors across major geographies that influence procurement, clinical deployment, and localized commercialization pathways

Geographic context shapes clinical adoption, reimbursement environments, and supply chain decisions in distinct ways. In the Americas, demand tends to concentrate around inpatient and emergency applications, supported by established procurement networks and an emphasis on rapid decision tools; this region also demonstrates a readiness to pilot innovative devices in tertiary care settings. In Europe, Middle East & Africa, heterogeneous regulatory frameworks and variable healthcare infrastructure create a mosaic of opportunities where localized clinical validation and partnerships with regional distributors are often decisive for market entry. In the Asia-Pacific region, rapid expansion of outpatient services and investment in diagnostic capabilities drive interest in scalable, cost-efficient pupillometry solutions, while also fostering local manufacturing investments that reduce lead times and tariff exposure.

Regional differences in clinical guidelines, reimbursement incentives, and capital procurement cycles affect how product features are prioritized. For instance, regions with high outpatient volumes may favor handheld devices that support decentralized screening programs, whereas markets with concentrated research funding and tertiary referral centers will adopt tabletop systems that provide deeper analytical capability. Supply chain strategies must therefore be regionally nuanced, balancing centralized manufacturing efficiency against the operational benefits of localized assembly, regulatory compliance, and service responsiveness. These factors collectively inform commercialization sequencing, partnership selection, and clinical evidence generation tailored to regional needs.

Competitive behavior and corporate strategies that define product differentiation, partnerships, manufacturing footprints, and service models among leading device makers

Competitive behavior among manufacturers and service providers reveals several recurring themes that shape the competitive landscape. First, product differentiation increasingly rests on software-enabled features-signal processing, automated artifact rejection, and decision-support-rather than hardware specifications alone. Companies investing in validated analytics and user-centered interfaces position themselves to capture clinical trust and to justify premium pricing that supports ongoing software maintenance and improvement. Second, strategic partnerships with healthcare systems, academic centers, and technology firms accelerate clinical validation and broaden the addressable use cases for devices, enabling quicker acceptance among key opinion leaders.

Manufacturers are also re-examining manufacturing footprints and distribution partnerships to manage cost and regulatory complexity. Those that secure resilient supplier networks, diversify assembly locations, and formalize long-term distributor collaborations gain operational flexibility and improved service levels. In addition, firms that develop comprehensive training and support services achieve higher retention among institutional customers by reducing perceived adoption risk. Finally, companies that transparently document validation protocols, device performance under variable conditions, and post-market surveillance practices build credibility with procurement committees and regulatory bodies, which in turn facilitates longer-term contracts and clinical adoption.

Operational and strategic recommendations for industry leaders to build resilience, accelerate adoption, and capture clinical credibility for pupillometer solutions

Industry leaders should prioritize a coordinated set of actions that align product development, supply chain strategy, and clinical evidence generation. First, invest in modular designs that allow component substitution without compromising regulatory compliance, thereby reducing exposure to tariff-driven cost shocks and enabling rapid supplier switches. Second, accelerate software validation efforts that demonstrate artifact-resistant measurement across diverse patient populations and operating environments; this approach strengthens clinical confidence and supports broader integration into care pathways.

Third, cultivate strategic partnerships with healthcare organizations and academic centers to co-design workflows and to produce peer-reviewed validation studies that address both neurology and ophthalmology applications. Fourth, expand after-sales services and training programs to lower the friction of adoption, particularly in outpatient clinics and diagnostic centers that may lack dedicated biomedical engineering support. Fifth, pursue a hybrid manufacturing and distribution model that combines regional assembly with centralized quality control to optimize lead times while maintaining consistent device performance. These measures, taken together, create a resilient commercial posture that supports sustainable growth, mitigates policy-related risk, and enhances clinical impact.

A robust research framework detailing data sources, validation practices, and analytical approaches underpinning the insights and conclusions presented in this report

The research approach combined qualitative and quantitative methods to ensure robust, triangulated insights. Primary interviews were conducted with clinicians, procurement professionals, and device engineers to gather firsthand perspectives on clinical requirements, operational constraints, and procurement drivers. Complementing these conversations, a systematic review of technical literature, regulatory filings, and device specifications was performed to map technology architectures, validation practices, and performance benchmarks. Supply chain mapping and supplier interviews provided additional granularity on component sourcing, lead times, and cost exposures.

Data synthesis involved cross-referencing clinical needs with technology capabilities to identify gaps and opportunities. Validation practices included reviewing clinical protocols for neurology and ophthalmology applications and assessing how devices performed under variable lighting, patient movement, and comorbidity conditions. The methodology incorporated clear inclusion criteria for interview participants and sources, documented potential biases, and applied sensitivity checks to key qualitative conclusions. Limitations are acknowledged and include the evolving nature of policy and regulatory guidance, which may influence supply chain configurations and adoption timelines; nonetheless, the mixed-methods approach provides a defensible foundation for the conclusions and recommendations presented.

Concise synthesis of market and technology dynamics with implications for stakeholders seeking to prioritize investments and operational responses in pupillometry

Pupillometry stands at an inflection point where technological maturity, clinical interest, and operational imperatives converge to create meaningful opportunity for improved diagnostic workflows and research applications. Advances in sensor technology and analytics have reduced traditional trade-offs between portability and data integrity, enabling a diversity of form factors that align with specific clinical and research needs. While policy shifts and tariff adjustments have introduced new operational considerations, they also catalyze strategic responses-regional assembly, supplier diversification, and design modularity-that improve long-term resilience.

For stakeholders, the imperative is to align product development with validated clinical use cases, to invest in software and services that lower adoption barriers, and to pursue partnerships that accelerate evidence generation. By doing so, manufacturers and healthcare organizations can transform pupillometry from a specialized measurement tool to a routinely used clinical instrument that contributes to faster triage, improved monitoring, and deeper research insights. The path forward requires coordinated action across development, validation, and commercialization, with an emphasis on flexibility and clinical credibility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pupillometer Market, by Type

  • 8.1. Handheld
  • 8.2. Tabletop

9. Pupillometer Market, by Technology

  • 9.1. Infrared
    • 9.1.1. Mid Infrared
    • 9.1.2. Near Infrared
  • 9.2. Optical
  • 9.3. Video Based
    • 9.3.1. 2D Imaging
    • 9.3.2. 3D Imaging

10. Pupillometer Market, by Distribution Channel

  • 10.1. Offline
    • 10.1.1. Direct Sales
    • 10.1.2. Distributors
  • 10.2. Online

11. Pupillometer Market, by Application

  • 11.1. Clinical Diagnosis
    • 11.1.1. Neurology
    • 11.1.2. Ophthalmology
  • 11.2. Screening

12. Pupillometer Market, by End User

  • 12.1. Clinics
  • 12.2. Diagnostic Centers
  • 12.3. Hospitals
  • 12.4. Research Institutes

13. Pupillometer Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pupillometer Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pupillometer Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pupillometer Market

17. China Pupillometer Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Adaptica S.r.l.
  • 18.6. AMETEK GmbH
  • 18.7. Brightlamp, Inc.
  • 18.8. Essilor Instruments USA, Inc.
  • 18.9. Good-Lite Company
  • 18.10. HAAG-STREIT AG
  • 18.11. IDMED S.A.S.
  • 18.12. Keeler Ltd.
  • 18.13. Konan Medical USA, Inc.
  • 18.14. Luneau Technology Group S.A.S.
  • 18.15. MediWorks Co., Ltd.
  • 18.16. NeurOptics, Inc.
  • 18.17. NIDEK Co., Ltd.
  • 18.18. OICO - Ophthalmic Instrument Company
  • 18.19. Reichert Technologies, Inc.
  • 18.20. Rodenstock GmbH
  • 18.21. Visionix Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PUPILLOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PUPILLOMETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PUPILLOMETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PUPILLOMETER MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PUPILLOMETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PUPILLOMETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PUPILLOMETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PUPILLOMETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PUPILLOMETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PUPILLOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PUPILLOMETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PUPILLOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PUPILLOMETER MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PUPILLOMETER MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PUPILLOMETER MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PUPILLOMETER MARKET SIZE, BY TABLETOP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PUPILLOMETER MARKET SIZE, BY TABLETOP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PUPILLOMETER MARKET SIZE, BY TABLETOP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PUPILLOMETER MARKET SIZE, BY INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PUPILLOMETER MARKET SIZE, BY INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PUPILLOMETER MARKET SIZE, BY INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PUPILLOMETER MARKET SIZE, BY MID INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PUPILLOMETER MARKET SIZE, BY MID INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PUPILLOMETER MARKET SIZE, BY MID INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PUPILLOMETER MARKET SIZE, BY NEAR INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PUPILLOMETER MARKET SIZE, BY NEAR INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PUPILLOMETER MARKET SIZE, BY NEAR INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PUPILLOMETER MARKET SIZE, BY OPTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PUPILLOMETER MARKET SIZE, BY OPTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PUPILLOMETER MARKET SIZE, BY OPTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PUPILLOMETER MARKET SIZE, BY VIDEO BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PUPILLOMETER MARKET SIZE, BY VIDEO BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PUPILLOMETER MARKET SIZE, BY VIDEO BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PUPILLOMETER MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PUPILLOMETER MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PUPILLOMETER MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PUPILLOMETER MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PUPILLOMETER MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PUPILLOMETER MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PUPILLOMETER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PUPILLOMETER MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PUPILLOMETER MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PUPILLOMETER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PUPILLOMETER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PUPILLOMETER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PUPILLOMETER MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PUPILLOMETER MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PUPILLOMETER MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PUPILLOMETER MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PUPILLOMETER MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PUPILLOMETER MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PUPILLOMETER MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PUPILLOMETER MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PUPILLOMETER MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PUPILLOMETER MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PUPILLOMETER MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PUPILLOMETER MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PUPILLOMETER MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PUPILLOMETER MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PUPILLOMETER MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PUPILLOMETER MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PUPILLOMETER MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PUPILLOMETER MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PUPILLOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PUPILLOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PUPILLOMETER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PUPILLOMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PUPILLOMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PUPILLOMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PUPILLOMETER MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PUPILLOMETER MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PUPILLOMETER MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PUPILLOMETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS PUPILLOMETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PUPILLOMETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GCC PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GCC PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. GCC PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 170. GCC PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. G7 PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. G7 PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 200. G7 PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 201. G7 PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. NATO PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. NATO PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 210. NATO PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 211. NATO PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL PUPILLOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES PUPILLOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA PUPILLOMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA PUPILLOMETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA PUPILLOMETER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA PUPILLOMETER MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA PUPILLOMETER MARKET SIZE, BY VIDEO BASED, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA PUPILLOMETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA PUPILLOMETER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA PUPILLOMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PUPILLOMETER MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PUPILLOMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)